John Paulson’s Pfizer PFE Stock Holding History

John Paulson’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-843,200	Closed	-$23.7M	–	92
2016 Q1	$23.7M	Buy	+843,200	New	+$24.1M	0.18%	50

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

John Paulson's PFE Position: Q2 2017 in Review

John Paulson sold out of Pfizer (PFE) in Q2 2017, closing a stake of 429,505 shares — an estimated $13.9M sold.

John Paulson first reported a position in PFE in Q4 2015 and held it in 6 quarters. The position peaked at $40.8M in Q1 2016. 2,050 funds tracked by Wall St. Rank hold PFE as of Q2 2017.

John Paulson reported no remaining Pfizer position as of Q2 2017 after selling out during the quarter.
John Paulson sold 429,505 Pfizer shares in Q2 2017, an estimated $13.9M.
John Paulson first reported a position in Pfizer in Q4 2015 and held it in 6 quarters.
John Paulson's Pfizer position peaked at $40.8M in Q1 2016.
2,050 funds tracked by Wall St. Rank held Pfizer as of Q2 2017.

Based on Paulson & Co's 13F filing for Q2 2017, filed 14 Aug 2017.